Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041743 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Haoran Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Genetic Therapy, Heart Valve Diseases, Cardiovascular Diseases, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Nature Science Foundation of Sichuan Province, 1.3.5 project for disciplines of excellence from West China Hospital of Sichuan University.
Abstract (Originalsprache)
Cardiovascular disease remains a leading cause of global mortality, with many unresolved issues in current clinical treatment strategies despite years of extensive research. Due to the great progress in nanotechnology and gene therapy in recent years, the emerging gene therapy based on nanocarriers has provided a promising therapeutic alternative for cardiovascular diseases. This review outlines the status of nanocarriers as vectors in gene therapy for cardiovascular diseases, including coronary heart disease, pulmonary hypertension, hypertension, and valvular heart disease. It discusses challenges and future prospects, aiming to support emerging clinical treatments. This review is the first to summarize gene therapy using nanocarriers for valvular heart disease, highlighting their potential in targeting challenging tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Cardiology, West China Hospital, Sichuan University, No.37 Guoxue Street, Chengdu 610041, China.
- Cardiac Structure and Function Research Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China.
Förderung
- National Natural Science Foundation of China
- Nature Science Foundation of Sichuan Province
- 1.3.5 project for disciplines of excellence from West China Hospital of Sichuan University
- West China Hospital of Sichuan University
Zitieren
APA
Yang, H., Li, J., Song, C., Li, H., Luo, Q., & Chen, M. (2025). Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041743
Vancouver
Yang H, Li J, Song C, Li H, Luo Q, Chen M. Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041743
BibTeX
@article{Yang2025,
author = {Yang, Haoran and Li, Junli and Song, Chengxiang and Li, Hongde and Luo, Qiang and Chen, Mao},
title = {Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041743}
}
EUVIMED